SGP

SpyGlass Pharma, Inc. SGP

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-19.86M

Quarter to Jun 30

Free cash flow

$-16.77M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$581.11M total
RA CAPITAL MANAGEMENT, L.P.
$178.55M0.0%
NEA Management Company, LLC
$164.55M0.0%
Sands Capital Ventures, LLC
$55.65M0.0%
Samsara BioCapital, LLC
$46.97M0.0%
BlackRock, Inc.
$15.84M+391.7%
PRICE T ROWE ASSOCIATES INC /MD/
$15.01M-4.3%
Vestal Point Capital, LP
$14.91M+0.5%
JPMORGAN CHASE & CO
$13.63M+9.1%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$12.24M0.0%
MILLENNIUM MANAGEMENT LLC
$11.29M+8.2%
abrdn plc
$10.98M+123.7%
VANGUARD CAPITAL MANAGEMENT LLC
$9.67M-0.1%
GEODE CAPITAL MANAGEMENT, LLC
$6.18M+119.2%
FRANKLIN RESOURCES INC
$5.20M-22.2%
Affinity Asset Advisors, LLC
$2.93M-47.4%
STATE STREET CORP
$2.62M+581.5%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$1.91M+43.7%
NORTHERN TRUST CORP
$1.84M+295.2%
VANGUARD PORTFOLIO MANAGEMENT LLC
$1.69M+1960.1%
VANGUARD FIDUCIARY TRUST CO
$1.52M+14.6%
Alyeska Investment Group, L.P.
$1.27M0.0%
TD ASSET MANAGEMENT INC
$1.06M0.0%
AMERIPRISE FINANCIAL INC
$1.02M+2.7%
ALPS ADVISORS INC
$755.3KNew
Bank of New York Mellon Corp
$533.0KNew
See all 52 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/SGP

Earnings Per Share

13fpro.ai/company/SGP

Loading ratio trend…

SGP insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About SpyGlass Pharma, Inc. (SGP): stock profile, AI score and financials

SpyGlass Pharma, Inc. (SGP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SGP is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), SpyGlass Pharma, Inc. reports net income of $-19.9M, free cash flow of $-16.8M. Top institutional holders of SGP by reported 13-F value include RA CAPITAL MANAGEMENT, L.P., NEA Management Company, Sands Capital Ventures, based on the most recent SEC filings. SGP trades on the Nasdaq exchange and files with the SEC under CIK 1778922. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SGP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SpyGlass Pharma, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1778922 →